Search results
Results from the WOW.Com Content Network
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
In February 2005, the company sued RADGames over their Super Add-On accessory board game that fit in the center of the board. [32] The judge initially issued an injunction on February 25, 2005, to halt production and sales before ruling in RADGames's favor in April 2005. [33] The Speed Die was added to all regular Monopoly sets in 2008. [29]
Boards.ie is a large Internet forum in Ireland.. As of January 2020, the site had more than 360,000 members, 3,200,000 threads and 64 million posts. [1] A wide variety of topics from entertainment (e.g. music, radio television, films) to jobs to politics to bereavement and to personal relationships are widely discussed, mostly from an Irish perspective.
Given that non-animu topics, not only on /b/ but also /g/, /k/, /v/, /sci/, /int/, etc etc "outnumber" animu topics, it would be wrong to claim that the site is dedicated to animu discussion; on the other hand, during the early stages of the site this was actually the case (non-animu boards weren't created until some time after 4chan first went ...
Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.
In February 2005, Takeda acquired San Diego, California, based Syrrx, a company specializing in high-throughput X-ray crystallography, for US$270 million. [14] In February 2008, Takeda acquired the Japanese operations of Amgen and rights to a dozen of the California biotechnology company's pipeline candidates for the Japanese market. [15]
In December 2005, Celgene received approval from the FDA to market Revlimid for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Focalin XR was later launched by Celgene and Novartis in 2005.
Psychiatrist Allen Frances told The New Yorker in 2017, “Most of the questionable practices that propelled the pharmaceutical industry into the scourge it is today can be attributed to Arthur Sackler.” [26] [65] Patrick Radden Keefe, author of the 2017 The New Yorker article later expanded his work into a full-length book Empire of Pain ...